Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
US-10513706-B2 · Dec 24, 2019 · US
US11834689B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11834689-B2 |
| Application number | US-202117196151-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 9, 2021 |
| Priority date | Jul 11, 2017 |
| Publication date | Dec 5, 2023 |
| Grant date | Dec 5, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
Opening claim text (preview).
What is claimed is: 1. A cell comprising: a. a nucleoside triphosphate transporter from Phaeodactylum tricornutum; b. a tRNA from Methanosarcina mazei or Methanococcus jannaschii comprising an anticodon, wherein the anticodon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from c. an aminoacyl tRNA synthetase from Methanosarcina or Methanococcus jannaschii ; and d. an mRNA comprising a codon, wherein the codon comprises a sequence selected from GGY, GYG, YGG, GAY, GYA, YGA, GCY, GYC, YGC, GUY, GYU, YGU, CAY, CYA, YCA, CGY, CYG, YCG, CUY, CYU, YCU, CCY, CYC, YCC, AAY, AYA, YAA, AGY, AYG, YAG, ACY, AYC, YAC, AUY, AYU, YAU, UUY, UYU, YUU, UAY, UYA, YUA, UGY, UYG, YUG, UCY, UYC, YUC, GYY, YGY, YYG, CYY, YCY, YYC, AYY, YAY, YYA, UYY, YUY, YYU, YYY, GGX, GXG, XGG, GAX, GXA, XGA, GCX, GXC, XGC, GUX, GXU, XGU, CAX, CXA, XCA, CGX, CXG, XCG, CUX, CXU, XCU, CCX, CXC, XCC, AAX, AXA, XAA, AGX, AXG, XAG, ACX, AXC, XAC, AUX, AXU, XAU, UUX, UXU, XUU, UAX, UXA, XUA, UGX, UXG, XUG, UCX, UXC, XUC, GXX, XGX, XXG, CXX, XCX, XXC, AXX, XAX, XXA, UXX, XUX, XXU, or XXX, and wherein each of Y and X are an unnatural nucleotide comprising an unnatural nucleobase selected from and wherein the anticodon of the tRNA pairs with the codon of the mRNA. 2. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the tRNA. 3. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the aminoacyl tRNA synthetase. 4. The cell of claim 1 , wherein the cell further comprises an oligonucleotide encoding the mRNA. 5. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA and the mRNA. 6. The cell of claim 1 , wherein the cell further comprises an oligonucleotide that encodes the tRNA, the mRNA, and the aminoacyl tRNA synthetase. 7. The cell of claim 1 , wherein the unnatural nucleobase in the anticodon is and the unnatural nucleobase in the codon is 8. The cell of claim 7 , wherein the unnatural nucleobase in the codon is and the unnatural nucleobase in the anticodon is 9. The cell of claim 1 , wherein the anticodon comprises the sequence GYT or GYC, wherein Y comprises the unnatural nucleobase. 10. The cell of claim 9 , wherein the unnatural nucleobase of Y is 11. The cell of claim 10 , wherein the unnatural nucleobase of Y is 12. The cell of claim 10 , wherein the unnatural nucleobase of Y is 13. The cell of claim 1 , wherein the codon comprises the sequence AXC or GXC, wherein X comprises the unnatural nucleobase. 14. The cell of claim 13 , wherein the codon comprises the sequence AXC. 15. The cell of claim 14 , wherein the unnatural nucleobase of X is 16. The cell of claim 14 , wherein the unnatural nucleobase of X is 17. The cell of claim 13 , wherein the codon comprises the sequence GXC. 18. The cell of claim 17 , wherein the unnatural nucleobase of X is 19. The cell of claim 17 , wherein the unnatural nucleobase of X is 20. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanosarcina barkeri. 21. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanococcus jannaschii. 22. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a pyrrolysyl tRNA synthetase. 23. The cell of claim 1 , wherein the aminoacyl tRNA synthetase is a tyrosyl tRNA synthetase. 24. The cell of claim 1 , wherein the cell is a microorganism or bacterium. 25. The cell of claim 1 , wherein the cell is an E. coli cell.
Ligases (6) · CPC title
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Pyrrolysine-tRNAPyl ligase (6.1.1.26) · CPC title
DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title
Stable introduction of foreign DNA into chromosome · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.